Cyclophosphamide (CY) is effective in inhibiting the formation of humoral antibody and prolonging the survival of foreign skin and tumor grafts (9, 15, 16) . The immunosuppressive properties of CY make it well suited to studies of immune mechanisms as well as in the treatment of neoplastic diseases. Specific tolerance to sheep red blood cells can be induced with a single injection of CY (11) . This suppression of antibody formation is complete up to 10 days, and recovery is gradual and incomplete for a considerably longer period of time (10) . The animal is unresponsive to a secondary dosage of antigen during the 10-day period (19, 20) . CY has been shown to be effective in the mouse, producing complete tolerance at dosages well below that which causes fatal toxicity (6, 10) .
Experimental mycotic infections in conjunction with CY treatment have not been reported. This study was designed to determine the effect of CY with its immunosuppressive action on the multiplication of Histoplasma capsulatum in the mouse system. Mice given relatively large dosages of H. capsulatum intraperitoneally (i.p.) rarely develop fatal infections (1, 17, 18) . A single dose of CY sufficient to inhibit antibody production to SRBC for 10 days was given to CBA/J mice. They were infected with varying concentrations of the yeast phase of the organism 24 Yeast-phase cultures were maintained on cysteine heart hemoglobin agar at 37 C.
Test animals. CBA/J mice ranging in age from 8 to 14 weeks, with an average weight of 30 g, were used throughout the investigation.
CY dosage. A total of 180 mice were injected i.p. with 200, 300, 340, or 400 mg of CY/kg of body weight as a freshly made saline solution containing 15 mg of CY/ml of saline (3, 4) . Five-tenths milliliter of 30% suspension (4.5 x 109 cells) of twice saline-washed fresh SRBC administered i.p. 24 h after CY injection was the tolerance-producing injection of antigen (3, 11, 19 Five mice from each of the resulting seven treatment groups were autopsied every 5 days for 20 days. Mice were killed with ether and immersed in amphyl. The lungs, livers, and spleens were aseptically removed, placed into separate sterile grinder tubes containing 5 ml of 0.1% cysteine saline, pH 6.5, and ground using sterile Teflon pestles. Samples (0.5 ml) of 1:10, 1:100, and 1: 1,000 dilutions of the homogenates were plated onto the surface of brain heart infusion agar containing 5% human blood plus 40 U of streptomycin and 20 U of penicillin per ml of medium. Plates were incubated at 25 C for 21 days, and colonies were counted.
An additional 140 mice were used for a lethality study. These were treated exactly as described above. (Table 1) showed a marked increase as compared to controls. The largest increase in numbers occurred with CY-treated mice injected with 107 yeast cells.
In the mice injected with 107 yeast cells, the number of parasites isolated from spleens of immunosuppressed mice increased from 12,450 5 days after infection to 19,720 after 10 days. This compared with 2,219 and 424 parasites isolated from spleens of non-immunosuppressed mice at the same time periods. The number of parasites isolated from livers of immunosuppressed mice increased from 7,435 5 days after infection to 141,270 after 10 days. Livers of non-immunosuppressed mice contained 4,220 and 1,083 parasites when autopsied at the same time periods. The increase in numbers of the parasites in the lungs of CY-treated mice was also significantly higher than in non-CY-treated animals.
More organisms were isolated from livers of mice than from other organs, irrespective of the infecting dose or treatment with CY by day 15 postinfection. We observed a general decrease in colony numbers obtained from all organs 15 days after infection whether animals were immunosuppressed or not.
A comparison of the number of cells of H. capsulatum obtained from spleens of CYtreated and control mice at various time intervals is depicted in Fig. 1 capsulatum from the peripheral blood of drugtreated and control mice was determined but not quantitated. Colonies were obtained from the blood of drug-treated mice infected with 10' yeast cells at days 10 and 15 postinfection.
Lung homogenates plated at a 1: 10 dilution showed some saprobic fungal contamination in all yeast cell concentrations plus CY and in CY controls. Trichoderma sp., Scopulariopsis sp., Aspergillus sp., and Penicillium sp. were commonly isolated. These fungi were occasionally isolated from spleen and liver homogenates in (12) and Sharbaugh and Grogan (22) .
The isolation of various fungal saprobes, especially in the lungs of CY-treated mice, agreed with previous reports of increased infection by opportunistic fungi (12, 13) . These reports are becoming more significant in light of the pathology now attributed to many of these so-called opportunistic fungi. Further studies need to be carried out to determine the interrelationships in compromised hosts.
Sharbaugh and Grogan (22) have shown that CY does not significantly inhibit phagocytosis by the reticuloendothelial system. It does destroy rapidly proliferating tissues-a cytotoxic activity (3, 7) . Immunological stimulation in the presence of specific inhibition of deoxyribonucleic acid synthesis with resultant cell death of a specific clone is a second action (3, 5, 7) . Spleen weight loss from CY-treated controls suggests that proliferating tissues are destroyed.
The use of CY-treated mice could increase the possibility of isolating viable organisms, since one of the procedures for isolating H. capsulatum and for assisting in the diagnosis of human histoplasmosis has involved animal inoculation, and mice are relatively unsusceptible to Histoplasma (18) . H. capsulatum isolated from infected tissue of CY-treated mice tended to grow more rapidly on artifical media than did the organism obtained from non-CY-treated mice. This suggests that immunocompetent cells carried over in culturing organs from non-CY-treated mice interfere with growth of 
